Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • An Initiative by Kendriya Vidyalaya Sangathan towards Digitilization and fulfilling their responsibility towards Environment Press Release
  • Mapmygenome partners with Thyrocare to offer preventive genetic tests Business
  • Worldwide EP ‘ATTACK’ by Techno diva Sara Krin Technology
  • CONTRIVANCE Artist Guild presents – Monsoon Strokes Lifestyle
  • Theobroma Reaches Milestone of 100 Outlets in India Business
  • India is favorite destination for Drone Technology Patent, said Mr. Binod Singh Business
  • Ten Colour Productions creates an ad film with Tiger Shroff for Great White Switches Business
  • Indian corporate employees facing increasing burnout at work post-pandemic Business

Optimus Announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir Conducted in India

Posted on July 21, 2021 By dsprime 10 Comments on Optimus Announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir Conducted in India

Hyderabad (Telangana) [India], July 21: Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild Covid-19 patients. With an acute shortage of antiviral drugs in the market against the SARS-CoV-2 infection, it is imperative that more drugs with potent antiviral activity against SARS-CoV-2 be introduced.

In a statement, the MD and Chairman Dr. D Srinivasa Reddy had declared that Optimus pharma has internally developed the active pharmaceutical ingredient (API) and the formulations for the product and had obtained approval for conducting Phase 3 Clinical Trial.

As per the clinical trial protocol approved, 1218 subjects with mild COVID-19 will be randomised in the study in a 1:1 ratio to Molnupiravir with the standard of care, or standard of care alone. The treatment duration is a maximum of 05 days and the total study duration will be a maximum of 28 days from randomisation.

“Optimus is all geared to immediately begin manufacturing of Molnupiravir for COVID-19 patients in India. The interim results on 353 patients have shown promising results of Molnupiravir. The drug has been successful in reducing viral load effectively with RT-PCR negativity achieved 78.3 % in the test arm compared to 48.4% in the standard of care arm on Day 5. Day 10 and Day 14 of the treatment duration have also given excellent results wherein the remaining patients have successfully achieved RT-PCR negativity. The trial has also revealed clinical improvement in a significantly high proportion of patient’s health. The safety of the drug has also been established with no observed side effects, co-morbidity, or morbidity observed during and after the treatment duration,” Chairman & Managing Director – Dr. D Srinivasa Reddy said.

Optimus has approached the Drugs Controller General of India (DCGI) to seek Emergency Use Authorization for Molnupiravir in India.

Optimus Pharma is committed to serve the nation and fight back the pandemic to restore normalcy in the lives of people affected by COVID-19 at the earliest. With the cooperation of the government and our stakeholders, and a special thanks to the Subject Expert Committee of the CDSCO for their valuable contribution and their recommendations to the project, we hope to deliver the product in India by leveraging our solid distribution strength across the country.

Press Release Tags:pr

Post navigation

Previous Post: Delhi Management Association and Benepik announce the Unsung Covid Heroes Award 2021
Next Post: Neel David wins Inspiring Hairstylist of the Year-2021 Award from Business Mint

Related Posts

  • Present Situation Mimics the Period Before the Second Wave Hit the Country Says Dr. Sairam Radhakrishna Press Release
  • Heritage Girls School, Udaipur, hosted its 5th edition of the TEDxHeritageGirlsSchool, an independently organized event Press Release
  • Online schooling is taking adaptability Press Release
  • Traders Union Releases List of Top 5 Best Brokers Press Release
  • Khabriya Reaches PAN India with 6000 News Reporters Press Release
  • National Institute of Technology in Andhra Pradesh Hosted Swavalambhi Bharat Abhiyan Event on Friday Press Release

Comments (10) on “Optimus Announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir Conducted in India”

  1. marizon ilogert says:
    October 9, 2022 at 6:01 pm

    Really fantastic information can be found on website.

  2. zmozeroteriloren says:
    November 23, 2022 at 6:11 am

    There’s noticeably a bundle to know about this. I assume you made sure nice points in features also.

  3. Top Places to Holiday in Amman (Jordan) says:
    December 18, 2022 at 1:03 am

    I think this is one of the so much important info for me. And i am satisfied studying your article. However should statement on few normal things, The website taste is ideal, the articles is really excellent : D. Just right task, cheers

  4. Handbook Guide to a Rover - FOURTEEN (Classic Handbook Car Guide) says:
    December 18, 2022 at 11:15 am

    I am so happy to read this. This is the type of manual that needs to be given and not the accidental misinformation that is at the other blogs. Appreciate your sharing this greatest doc.

  5. How to Become a Screw-machine Tender says:
    December 18, 2022 at 3:10 pm

    I delight in, lead to I found just what I used to be having a look for. You’ve ended my 4 day lengthy hunt! God Bless you man. Have a great day. Bye

  6. Top Places to See in Port Louis (Mauritius) says:
    December 18, 2022 at 11:07 pm

    Wow, amazing blog layout! How long have you been blogging for? you made blogging look easy. The overall look of your web site is excellent, let alone the content!

  7. The Best Places to Drink in Aurangabad (India) says:
    December 20, 2022 at 5:06 am

    It’s actually a cool and helpful piece of information. I’m happy that you just shared this useful info with us. Please keep us informed like this. Thanks for sharing.

  8. How to Start a Photographic Light Meters Business (Beginners Guide) says:
    December 22, 2022 at 4:54 pm

    I needed to compose you that little observation to help say thanks a lot over again with your exceptional secrets you have provided at this time. It was so extremely open-handed of people like you to give publicly just what some people would have offered for sale for an e book in making some profit for their own end, even more so seeing that you could have tried it if you desired. These advice additionally acted to be the good way to fully grasp that other people online have the same fervor similar to mine to understand a little more in respect of this issue. I am sure there are thousands of more fun moments ahead for individuals who see your site.

  9. Beginners Guide to Growing Tillandsia (air plant, Spanish moss) (Home & Garden Handbook) says:
    December 23, 2022 at 9:00 am

    Some times its a pain in the ass to read what people wrote but this internet site is very user friendly! .

  10. How to Become a Homemaker says:
    December 27, 2022 at 4:41 pm

    Thanks a lot for sharing this with all of us you actually know what you’re talking about! Bookmarked. Kindly also visit my site =). We could have a link exchange arrangement between us!

Leave a Reply Cancel reply

Your email address will not be published.

Recent Posts

  • On This ‘WORLD CANCER DAY’: 8 Best Oncologists Share Their Advice on Increasing Risks of Cancer.
  • ‘My Company is My Family; My Family is not My Company’, proponent Govindkaka of Shree Ramkrishna Exports Pvt. Ltd honoured with 2022 Hurun Most Respected Family Business of the Year Award
  • CricAdda and Sanjay Dutt: A winning combination for sports fans and gamers
  • Sakhiya Skin Clinic is India’s No. 1 skin clinic chain
  • Aditya Prakash, Bollywood Actor and Writer shares his secret of a happy & successful life

Recent Comments

  • Kimgab on Greenman Viral Desai to stage Satyagraha against Environment Pollution as part of Azadi Ka Amrut Mahotsav
  • MichaelMit on Greenman Viral Desai to stage Satyagraha against Environment Pollution as part of Azadi Ka Amrut Mahotsav
  • prinses unicorn kleurplaat on Ace of Spades PR Agency: Who Should Get Published in the Press?
  • získat více informací on Karda Constructions Ltd. Board of Directors Recommend Issuance of Bonus Shares in 4:1 Ratio
  • мега тор on Gururo.com collaborates with IU University, Germany to Offer World-Class Post Graduate Certificate in Program Management
  • IOCL Ahmedabad organized an exhibition on Biofuels as a part of the Azadi Ka Amrut Mahotsav celebrations Press Release
  • Matific Math League 2022 Witnesses a Record-Breaking Million Participants, Noida Bal Bharti Public School Wins Business
  • Abhishti: Revving up the world of apparel through their exquisite range Business
  • Meet Preeti Jaiin Bokdia, a middle-class woman who founded India’s first women’s empowerment platform (WOW-Wings for Dreams) Lifestyle
  • Garv Foundation celebrates the grand success of ‘Garv Awards’ Business
  • Maverick Entrepreneur Ledian Agallijaj – Born for ballet or just privileged ? Business
  • B612 adds ‘Create your own filter’ to their tools for innovation Business
  • Atal Gaurav Ratna Award 2021 was successfully conducted in Bhopal, Madhya Pradesh by Atal Bharat Sports & Cultural Association Press Release

Copyright © 2023 Daily News India.

Powered by PressBook News WordPress theme